CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Return on Equity [ROE] (2013 - 2020)

Updated

CytoDyn's Return on Equity [ROE] was -107737.98% in fiscal Q1 2021 (quarter ended Aug 31, 2020).

Analysis

CytoDyn (CYDY) Return on Equity [ROE] (2013 - 2020) Analysis & Trends

For FY2017 (ended May 31, 2017), Return on Equity [ROE] at CytoDyn came in at -566.10%.

  • Return on Equity [ROE] shows a three-year change of +106.17 percentage points (FY2014 to FY2017).
  • In earlier fiscal years, Return on Equity [ROE] was -672.27% in FY2014.
  • The fiscal Q1 2021 figure marks the highest quarterly Return on Equity [ROE] in data going back to fiscal Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 CytoDyn 274.70 Mn 274.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2020 -107,737.98%
May 31, 2017 -1,194.50%
Feb 28, 2017 -471.23%
Nov 30, 2016 -384.62%
Aug 31, 2016 -269.31%
May 31, 2016 -240.09%
Feb 29, 2016 -781.62%
Aug 31, 2014 -575.24%
May 31, 2014 -232.63%
Feb 28, 2014 -146.66%
Nov 30, 2013 -242.66%
Feb 28, 2013 -22,987.00%
API Access

CytoDyn Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYDY&period=max&api_key=YOUR_API_KEY